Neogene TherapeuticsListed
neogene.combiotech_life_sciences
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR)…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR)…
SparingVision is a clinical-stage genomic medicines company focused on developing innovative treatments for ocular diseases, particularly inherited retinal diseases (IRDs) such as…
Pulmocide is a biopharmaceutical company that specializes in tackling difficult-to-treat respiratory diseases, focusing on respiratory fungal infections. Their lead product, opelc…
Alentis is a clinical-stage biotech company developing anti-Claudin-1 therapies targeting solid tumors and fibrosis. The company focuses on monoclonal antibodies and antibody-drug…
Quell Therapeutics is dedicated to discovering, developing, and delivering pioneering Treg therapies to durably transform the lives of people suffering from immune-mediated diseas…
Advesya is a French/Swiss clinical-stage biotech company transforming the fight against cancer and autoimmune diseases by targeting IL-1RAP, a unique antigen upregulated in variou…
NMD Pharma discovers and develops novel therapeutics for neuromuscular diseases, focusing on small molecule inhibitors of skeletal muscle-specific ClC-1 ion channels. Their lead c…
EyeBio is a subsidiary of Merck focused on developing therapies aimed at protecting, restoring, and improving vision for people living with eye diseases, particularly retinal dise…
CDR-Life is focused on transforming the treatment of cancer and autoimmune diseases through its innovative T cell engager (TCE) platform, M-gager®. The company develops highly sel…
HI-Bio is a clinical-stage biotechnology company focused on discovering and developing precision medicines for patients suffering from immune-mediated diseases (IMDs). The company…
CatalYm is pioneering the neutralization of GDF-15 to overcome cancer therapy resistance, developing safe and efficacious immune therapies for solid tumors, particularly focusing…
Noema Pharma is a clinical-stage biotech developing a late-stage portfolio of oral small molecule therapeutics with well-characterized mechanisms and unique features aimed at deli…
Corteria Pharmaceuticals is focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure, sarcopenia, and obesity su…
Aviceda Therapeutics is a clinical-stage biotech company focused on developing novel therapies for immune-mediated diseases, particularly targeting macular degeneration, a leading…
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. Their lead product candid…
Callio Therapeutics is developing next-generation, dual-payload antibody-drug conjugates (ADCs) that enable targeted delivery of drug combinations to tumor cells, aiming to maximi…
Augustine Therapeutics is pioneering a new era in HDAC6-targeted drug development, focusing on selective inhibition of HDAC6 for treating chronic diseases, particularly in neuromu…
Azafaros is a clinical-stage company focused on developing therapies for severe rare metabolic disorders, particularly lysosomal storage disorders. Their lead program, nizubaglust…
ReproNovo is a clinical-stage biopharmaceutical company focused on developing innovative therapies for male and female fertility and women's health, addressing critical gaps in tr…
Odyssey Therapeutics is focused on transforming the standard of care for patients with autoimmune and inflammatory diseases by targeting upstream signaling nodes and mechanisms in…
Alveus Therapeutics is focused on developing next-generation metabolic therapies aimed at sustainable weight loss and improved patient outcomes in the obesity treatment landscape.
Adcendo ApS is a clinical-stage biotech company focused on developing first- and best-in-class antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical…
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases. The company focuses on creating…